This biopharmaceutical company specializes in the research, development, production, and marketing of recombinant protein therapeutics and microecological agents. They focus on treating a range of conditions including antiviral, oncology, immunology, hematology, digestive disorders, and degenerative diseases. The company boasts seven world-leading technology platforms, including recombinant protein secretion and expression, long-acting recombinant proteins, and antibody technology. Their product portfolio includes recombinant protein therapeutics such as Human Erythropoietin (EPOSINO), Human Interferon α1b (SINOGEN), and Human Granulocyte Colony-stimulating Factor (WHITE-C), as well as the microecological agent "Combined Clostridium Butyricum and Bifidobacterium (CLOBICO)". The company has a strong presence in major markets such as North America, the EU, Brazil, the Philippines, and Indonesia.
Manufacturer usually replies in 7 days